News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
607,189 Results
Type
Article (46501)
Company Profile (238)
Press Release (560450)
Section
Business (165947)
Career Advice (2057)
Deals (27889)
Drug Delivery (105)
Drug Development (85505)
Employer Resources (155)
FDA (15108)
Job Trends (13258)
News (297480)
Policy (27574)
Tag
2024 BioCapital Digital (11)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (6)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (15)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (4)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (10)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (2)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2714)
Academic (1)
Accelerated approval (3)
Adcomms (29)
Allergies (84)
Alliances (44157)
ALS (88)
Alzheimer's disease (1421)
Antibody-drug conjugate (ADC) (123)
Approvals (15065)
Artificial intelligence (244)
Autoimmune disease (17)
Automation (14)
Bankruptcy (241)
Best Places to Work (10906)
BIOSECURE Act (18)
Biosimilars (97)
Biotechnology (178)
Bladder cancer (58)
Brain cancer (28)
Breast cancer (257)
Cancer (1983)
Cardiovascular disease (165)
Career advice (1710)
Career pathing (29)
CAR-T (154)
Cell therapy (414)
Cervical cancer (17)
Clinical research (69596)
Collaboration (762)
Compensation (372)
Complete response letters (27)
COVID-19 (2742)
CRISPR (37)
C-suite (190)
Cystic fibrosis (101)
Data (1850)
Decentralized trials (2)
Denatured (19)
Depression (47)
Diabetes (245)
Diagnostics (6201)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (37)
Drug discovery (108)
Drug pricing (109)
Drug shortages (25)
Duchenne muscular dystrophy (81)
Earnings (62498)
Editorial (35)
Employer branding (20)
Employer resources (133)
Events (91414)
Executive appointments (600)
FDA (16165)
Featured Employer (49)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (667)
Gene editing (102)
Generative AI (25)
Gene therapy (294)
GLP-1 (737)
Government (4129)
Grass and pollen (4)
Guidances (46)
Healthcare (18172)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (115)
Indications (25)
Infectious disease (2879)
Inflammatory bowel disease (140)
Inflation Reduction Act (9)
Influenza (49)
Intellectual property (72)
Interviews (367)
IPO (13512)
IRA (44)
Job creations (2757)
Job search strategy (1446)
Kidney cancer (10)
Labor market (27)
Layoffs (432)
Leadership (15)
Legal (5276)
Liver cancer (74)
Lung cancer (290)
Lymphoma (131)
Machine learning (2)
Management (51)
Manufacturing (252)
MASH (65)
Medical device (12265)
Medtech (12268)
Mergers & acquisitions (14861)
Metabolic disorders (657)
Multiple sclerosis (69)
NASH (22)
Neurodegenerative disease (88)
Neuropsychiatric disorders (28)
Neuroscience (1915)
NextGen: Class of 2025 (6212)
Non-profit (4248)
Northern California (2224)
Now hiring (20)
Obesity (360)
Opinion (235)
Ovarian cancer (68)
Pain (82)
Pancreatic cancer (76)
Parkinson's disease (132)
Partnered (15)
Patents (178)
Patient recruitment (93)
Peanut (49)
People (48440)
Pharmaceutical (53)
Pharmacy benefit managers (18)
Phase I (21827)
Phase II (30620)
Phase III (22948)
Pipeline (901)
Podcasts (65)
Policy (107)
Postmarket research (2576)
Preclinical (8413)
Press Release (63)
Prostate cancer (93)
Psychedelics (37)
Radiopharmaceuticals (262)
Rare diseases (382)
Real estate (5324)
Recruiting (66)
Regulatory (20093)
Reports (33)
Research institute (2451)
Resumes & cover letters (342)
Rett syndrome (3)
RNA editing (2)
RSV (41)
Schizophrenia (69)
Series A (118)
Series B (76)
Service/supplier (11)
Sickle cell disease (53)
Southern California (1956)
Special edition (18)
Spinal muscular atrophy (153)
Sponsored (29)
Startups (3222)
State (2)
Stomach cancer (13)
Supply chain (61)
The Weekly (45)
United States (19409)
Vaccines (719)
Venture capitalists (32)
Webinars (11)
Weight loss (252)
Women's health (34)
Worklife (16)
Date
Today (164)
Last 7 days (590)
Last 30 days (2934)
Last 365 days (32925)
2025 (6847)
2024 (34148)
2023 (38579)
2022 (49437)
2021 (53196)
2020 (51066)
2019 (44060)
2018 (33134)
2017 (30725)
2016 (29369)
2015 (33828)
2014 (25662)
2013 (20714)
2012 (22027)
2011 (22731)
2010 (20893)
Location
Africa (734)
Alabama (47)
Alaska (6)
Arizona (160)
Arkansas (14)
Asia (36393)
Australia (6523)
California (5124)
Canada (1646)
China (444)
Colorado (228)
Connecticut (246)
Delaware (109)
Europe (82889)
Florida (739)
Georgia (176)
Idaho (54)
Illinois (424)
India (19)
Indiana (280)
Iowa (5)
Japan (128)
Kansas (94)
Kentucky (24)
Louisiana (9)
Maine (37)
Maryland (752)
Massachusetts (3824)
Michigan (192)
Minnesota (322)
Mississippi (2)
Missouri (76)
Montana (31)
Nebraska (21)
Nevada (47)
New Hampshire (66)
New Jersey (1411)
New Mexico (29)
New York (1459)
North Carolina (883)
North Dakota (8)
Northern California (2224)
Ohio (181)
Oklahoma (15)
Oregon (36)
Pennsylvania (1130)
Puerto Rico (7)
Rhode Island (25)
South America (1008)
South Carolina (15)
Southern California (1956)
Tennessee (86)
Texas (775)
Utah (156)
Virginia (124)
Washington D.C. (54)
Washington State (478)
West Virginia (3)
Wisconsin (44)
607,189 Results for "high point clinical trials center".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
glp-1
Novo Nordisk Links High-Dose Wegovy to Increased Weight Loss in Phase III Trial
The data suggest the high dose nearly closes the efficacy gap with Zepbound.
January 17, 2025
·
3 min read
·
Nick Paul Taylor
Press Releases
The University of Colorado Cancer Center and Flatiron Health Announce Collaboration to Drive More Efficient Clinical Trials
March 5, 2025
·
4 min read
Press Releases
Vaxxas Completes Enrollment for Largest Clinical Trial of High-Density Microarray Patch (HD-MAP) For Vaccine Delivery
February 18, 2025
·
6 min read
Press Releases
Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial
February 26, 2025
·
4 min read
Press Releases
Breathe BioMedical Launches Multi-Center Clinical Trial of its Breath Test for Breast Cancer at George Washington University Breast Center
February 25, 2025
·
3 min read
Press Releases
LIXTE Adds Northwestern University’s Lurie Cancer Center as Second Site in Ongoing Clinical Trial for Ovarian Clear Cell Cancer
February 25, 2025
·
4 min read
Press Releases
Bantam Pharmaceutical Announces Activation of First Phase 1 Clinical Trial Site at MD Anderson Cancer Center
February 20, 2025
·
3 min read
BioMidwest
University Cancer & Blood Center and University Health Alliance open High-Risk GI Clinic to address community needs
University Cancer & Blood Center, a leading oncology and hematology practice for Northeast Georgia, and University Health Alliance, a multi-disciplinary practice focusing on prevention and coordinated care, announce the opening of their High-Risk GI Clinic.
April 10, 2024
·
3 min read
Press Releases
Akeso Announces Completion of Patient Enrollment in The Phase III Clinical Trial of Cadonilimab for Adjuvant Treatment of High-Risk Recurrent Hepatocellular Carcinoma
March 5, 2025
·
4 min read
Drug Development
University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx’s Pivotal Phase III TIGeR-PaC Clinical Trial
RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, announced today that the University of Nebraska Medical Center (UNMC) is now enrolling patients with Locally Advanced Pancreatic Cancer (LAPC) in the Company’s ongoing pivotal Phase III TIGeR-PaC clinical trial.
June 26, 2024
·
9 min read
1 of 60,719
Next
